Document Detail

Human renalase: a review of its biology, function, and implications for hypertension.
MedLine Citation:
PMID:  23107895     Owner:  NLM     Status:  Publisher    
Renalase is a novel flavoprotein, highly expressed in kidney and heart, which metabolizes catecholamines and catecholamine-like substances via a superoxide (O2(-))-dependent mechanism using nicotinamide adenine dinucleotide (NADH) as a cofactor. Its mechanism of action is distinct from that of monoaminooxidases A and B, because it oxidizes catecholamines (epinephrine>L-DOPA>dopamine = norepinephrine) to aminochrome, and the reaction rate increases ∼4- to 6-fold in presence of NADH. Tissue and plasma renalase levels are decreased in animal models of chronic kidney disease, and renalase deficiency is associated with increased blood pressure and elevated circulating catecholamines. Renalase plasma levels, measured by enzyme-linked immunosorbent assay, are reported to be ∼ 5-fold higher in patients with end-stage renal disease than in normal control subjects. They were also increased in kidney and heart transplant recipients, and inversely correlated with estimated glomerular filtration rate. Renalase has potential therapeutic applications. Experimental models demonstrate that the chronic administration of renalase decreases ambulatory blood pressure and prevents the development of cardiac hypertrophy in rats, and that its acute administration decreases ischemic acute kidney injury in mice. Here we provide a detailed review of renalase biology including its mechanism of action, secretion into blood, interaction with the renal dopamine and epinephrine system, and early studies evaluating its association with outcomes related to hypertension and target-organ injury.
Gary V Desir; Ling Wang; Aldo J Peixoto
Related Documents :
3710555 - Estimation of intrasynaptic norepinephrine concentrations in humans.
15333425 - Dopexamine reverses the vasopressin-associated impairment in tissue oxygen supply but d...
23291365 - Effects of chronic sdma infusion on glomerular filtration rate, blood pressure, myocard...
8751515 - Protamine-induced hypotension in heart operations: application of the concept of ventri...
15447115 - Discontinuous tangential stress in double wall carbon nanotubes.
7060625 - Reduction in intraocular pressure induced by colchicine and related compounds.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-26
Journal Detail:
Title:  Journal of the American Society of Hypertension : JASH     Volume:  -     ISSN:  1878-7436     ISO Abbreviation:  J Am Soc Hypertens     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312518     Medline TA:  J Am Soc Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
Medical Service, VA Connecticut Healthcare System, West Haven, CT, and Section of Nephrology, Yale University School of Medicine, New Haven, CT. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsarta...
Next Document:  Urinary arginine methylation index associated with ambulatory blood pressure abnormalities in childr...